Inherited Retinal Degenerations: Current Landscape and Knowledge Gaps

Affiliations

¹ Department of Ophthalmology, University of California, San Francisco, San Francisco, CA, USA.
² Ocular Genomics Institute, Massachusetts Eye and Ear Infirmary, Harvard Medical School, Boston, MA, USA.
³ Foundation Fighting Blindness, Columbia, MD, USA.
⁴ Human Genetics Center, School of Public Health, and Ruiz Department of Ophthalmology and Visual Science, The University of Texas Health Science Center, Houston, TX, USA.
⁵ Rose-Silverthorne Retinal Degenerations Laboratory, Retina Foundation of the Southwest, Dallas, TX, USA.
⁶ Department of Ophthalmology, University of Florida, Gainesville, FL, USA.
⁷ Center for Retinal Degenerations and Ophthalmic Genetic Diseases, Department of Ophthalmology, Duke University School of Medicine, Durham, NC, USA.
⁸ Vision Science, the Helen Wills Neuroscience Institute, the Department of Molecular and Cell Biology, University of California, Berkeley, CA, USA.
⁹ Department of Ophthalmology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.
¹⁰ Institut de la Vision-Sorbonne Université, Inserm, CNRS-Paris, France.
¹¹ Departments of Ophthalmology, Neuroscience, Molecular Biology and Genetics, and Institute of Genetic Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
¹² Institute of Ophthalmology and Visual Science, Rutgers-New Jersey Medical School, Rutgers University, Newark, NJ, USA.

Jacque L Duncan et al. Transl Vis Sci Technol. 2018.

. 2018 Jul 18;7(4):6.

doi: 10.1167/tvst.7.4.6. eCollection 2018 Jul.

¹ Department of Ophthalmology, University of California, San Francisco, San Francisco, CA, USA.
² Ocular Genomics Institute, Massachusetts Eye and Ear Infirmary, Harvard Medical School, Boston, MA, USA.
³ Foundation Fighting Blindness, Columbia, MD, USA.
⁴ Human Genetics Center, School of Public Health, and Ruiz Department of Ophthalmology and Visual Science, The University of Texas Health Science Center, Houston, TX, USA.
⁵ Rose-Silverthorne Retinal Degenerations Laboratory, Retina Foundation of the Southwest, Dallas, TX, USA.
⁶ Department of Ophthalmology, University of Florida, Gainesville, FL, USA.
⁷ Center for Retinal Degenerations and Ophthalmic Genetic Diseases, Department of Ophthalmology, Duke University School of Medicine, Durham, NC, USA.
⁸ Vision Science, the Helen Wills Neuroscience Institute, the Department of Molecular and Cell Biology, University of California, Berkeley, CA, USA.
⁹ Department of Ophthalmology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.
¹⁰ Institut de la Vision-Sorbonne Université, Inserm, CNRS-Paris, France.
¹¹ Departments of Ophthalmology, Neuroscience, Molecular Biology and Genetics, and Institute of Genetic Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
¹² Institute of Ophthalmology and Visual Science, Rutgers-New Jersey Medical School, Rutgers University, Newark, NJ, USA.

No abstract available

References

1. RetNet. Available at: http://www.sph.uth.tmc.edu/RetNet/ Accessed July 9, 2018.
1. Berson EL, Rosner B., Sandberg MA, et al. A randomized trial of vitamin A and vitamin E supplementation for retinitis pigmentosa. Arch Ophthalmol. 1993;111:761–772. - PubMed
1. Berson EL, Rosner B., Sandberg MA, et al. Clinical trial of docosahexaenoic acid in patients with retinitis pigmentosa receiving vitamin A treatment. Arch Ophthalmol. 2004;122:1297–1305. - PubMed
1. Bennett J., Wellman J., Marshall KA, et al. Safety and durability of effect of contralateral-eye administration of AAV2 gene therapy in patients with childhood-onset blindness caused by RPE65 mutations: a follow-on phase 1 trial. Lancet. 2016;388:661–672. - PMC - PubMed
1. Cideciyan AV, Aleman TS, Boye SL, et al. Human gene therapy for RPE65 isomerase deficiency activates the retinoid cycle of vision but with slow rod kinetics. Proc Natl Acad Sci U S A. 2008;105:15112–15117. - PMC - PubMed